Scrip Regulatory Affairs
Health professions alliance calls for urgent action on medtech counterfeiting
21 May 2010
Bernard Murphy; Karen Finn
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- IMI plans "unprecedented" programme for novel antibiotics as drug resistance continues to rise
- US govt panel wants FDA to consider cybersecurity in pre- and post-market device reviews
- US legislation seeks to give generics labelling change abilities
- Counterfeit drug seizures up by almost 200% in 2011, says White House IP report
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
